Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1033-1048
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The journey of boswellic acids from synthesis to pharmacological activities
Ehab A. Ragab, Mohammed F. Abd El-Wahab, Ahmed S. Doghish, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1477-1504
Open Access | Times Cited: 21
Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
Ankit Kumar Dubey, Suman Kumar Chaudhry, Harikesh Bahadur Singh, et al.
Biotechnology Reports (2022) Vol. 33, pp. e00712-e00712
Open Access | Times Cited: 29
Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review
Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan‐Karnak, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 27
Identification of new pharmacophore against SARS-CoV-2 spike protein by multi-fold computational and biochemical techniques
Atta Ullah, Saeed Ullah, Sobia Ahsan Halim, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.
Jency Roshni, R. Vaishali, KS Ganesh, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 6, pp. 662-669
Open Access | Times Cited: 19
Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
Sofia Kokkinis, Manisha Singh, Keshav Raj Paudel, et al.
Food Bioscience (2024) Vol. 58, pp. 103761-103761
Open Access | Times Cited: 3
Fruits as nutraceuticals: A review of the main fruits included in nutraceutical patents
Natália Casas Mesa, Izabel Almeida Alves, Fernanda Maria Pinto Vilela, et al.
Food Research International (2023) Vol. 170, pp. 113013-113013
Closed Access | Times Cited: 9
Boswellic acid coated zinc nanoparticles attenuate NF-κB-mediated inflammation in DSS-induced ulcerative colitis in rats
Eman S Abou Zaid, Somya Z. Mansour, Sawsan M. El-Sonbaty, et al.
International Journal of Immunopathology and Pharmacology (2023) Vol. 37
Open Access | Times Cited: 8
Transgenerational hormesis in healthy aging and antiaging medicine from bench to clinics: Role of food components
Vittorio Calabrese, Naomi Osakabe, Rosalba Siracusa, et al.
Mechanisms of Ageing and Development (2024) Vol. 220, pp. 111960-111960
Closed Access | Times Cited: 2
Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors
Syeda Warisul Fatima, Shahenvaz Alam, Sunil Kumar Khare
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100241-100241
Open Access | Times Cited: 12
Effect of Boswellic acids on T cell proliferation and activation
Abdo Meyiah, Murtada Y. Shawkat, Najeeb Ur Rehman, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110668-110668
Closed Access | Times Cited: 6
Phase III randomized clinical trial of BV‐4051, an Ayurvedic polyherbal formulation in moderate SARS‐CoV‐2 infections and its impact on inflammatory biomarkers
Deepa Chitre, Satej Nadkarni, Namdev Jagtap, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 4, pp. 1232-1241
Open Access | Times Cited: 10
Potential therapeutic effects of boswellic acids/Boswellia serrata extract in the prevention and therapy of type 2 diabetes and Alzheimer’s disease
Adel A. Gomaa, Hanan A. Farghaly, Yasmin A. Abdel-Wadood, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 11, pp. 2167-2185
Closed Access | Times Cited: 13
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial
Sepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 465-475
Open Access | Times Cited: 9
Modulation of NRF-2 Pathway Contributes to the Therapeutic Effects of Boswellia serrata Gum Resin Extract in a Model of Experimental Autoimmune Myocarditis
Ramona D’Amico, Roberta Fusco, Marika Cordaro, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2129-2129
Open Access | Times Cited: 9
Insights into Frankincense and Myrrh Research: A Comprehensive Analytical Study of Patterns and Perspectives
Siddig İbrahim Abdelwahab, Manal Mohamed Elhassan Taha, Ahmed Ali Jerah, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38102-e38102
Open Access | Times Cited: 1
Edge advances in nanodrug therapies for osteoarthritis treatment
Jinfeng Liao, Qinxuan Gu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed Gomaa
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 1977-1992
Open Access | Times Cited: 7
From genes to systems: The role of food supplementation in the regulation of sepsis-induced inflammation
Yolanda Prado, Diego Aravena, Sebastián Gatica, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166909-166909
Open Access | Times Cited: 3
Boswellia: Systematically scoping the in vitro, in vivo and clinical research
Karen Pilkington, Geoffrey J. Pilkington
European Journal of Integrative Medicine (2022) Vol. 56, pp. 102197-102197
Open Access | Times Cited: 5
β-Boswellic Acid Suppresses Breast Precancerous Lesions via GLUT1 Targeting-Mediated Glycolysis Inhibition and AMPK Pathway Activation
Fengjie Bie, Guijuan Zhang, Xianxin Yan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVID
Norman Gaylis, Ida Kreychman, J. Sagliani, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 4
Can the golden nutraceutical frankincense combat COVID‐19?
Hidayat Hussain
Future Postharvest and Food (2024) Vol. 1, Iss. 1, pp. 161-165
Open Access
Immunomodulatory effects of herbal extract mixture of Boswellia serrata, Commiphora myrrha, and propolis in a forced swimming-induced mouse model of immune dysfunction
Kyung Min Lim, Ju Hye Song, Eun Yeong Lim, et al.
Applied Food Research (2024), pp. 100662-100662
Open Access
Page 1 - Next Page

Scroll to top